Prestige Biologics Co., Ltd. (334970) Price & Analysis

― Followers

334970 Stock Chart & Stats

$1790.00

$4.00(0.22%)

Jul 30, 2026

―

Day’s Range― - ―

52-Week Range$1,650.00 - $3,950.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩138.87B

Enterprise Value$271.42K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta>-0.01

Next Earnings

Sep 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-188.41

Shares Outstanding77,752,640

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

334970 FAQ

What was Prestige Biologics Co., Ltd.’s price range in the past 12 months?

Prestige Biologics Co., Ltd. lowest stock price was $1650.00 and its highest was $3950.00 in the past 12 months.

What is Prestige Biologics Co., Ltd.’s market cap?

Prestige Biologics Co., Ltd.’s market cap is ₩138.87B.

When is Prestige Biologics Co., Ltd.’s upcoming earnings report date?

Prestige Biologics Co., Ltd.’s upcoming earnings report date is Sep 18, 2026 which is in 49 days.

How were Prestige Biologics Co., Ltd.’s earnings last quarter?

Prestige Biologics Co., Ltd. released its earnings results on May 15, 2026. The company reported -$188.413 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Prestige Biologics Co., Ltd. overvalued?

According to Wall Street analysts Prestige Biologics Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Prestige Biologics Co., Ltd. pay dividends?

Prestige Biologics Co., Ltd. does not currently pay dividends.

What is Prestige Biologics Co., Ltd.’s EPS estimate?

Prestige Biologics Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Prestige Biologics Co., Ltd. have?

Prestige Biologics Co., Ltd. has 77,752,640 shares outstanding.

What happened to Prestige Biologics Co., Ltd.’s price movement after its last earnings report?

Prestige Biologics Co., Ltd. reported an EPS of -$188.413 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.476%.

Which hedge fund is a major shareholder of Prestige Biologics Co., Ltd.?

Currently, no hedge funds are holding shares in KR:334970

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology